Use of glucagon-like peptide-1 (GLP-1) or analogues to abolish catabolic changes after surgery

摘要

This invention provides a compound selected from GLP-1, GLP-1 analogues, GLP-1 derivatives, and pharmaceutically-acceptable salts thereof for use in the attenuation of post-surgical catabolic changes and insulin resistance.